Dr. Peter Kash, Ed.D/MBA, is a co-founder of TargImmune Therapeutics and iOncologi and serves as Chairman of Camelot BioCapital. Over his three-decade career, he has co-founded more than a dozen biotech companies, raising over $2 billion in private and public financing with a combined peak market capitalization exceeding $20 billion. Seven drugs from his portfolio companies have received FDA approval, and Camelot is currently leading the development of six novel therapies in oncology and autoimmune diseases.

Dr. Kash has contributed significantly to academia, serving as an Adjunct Professor of Entrepreneurship at the Wharton Business School and as a Visiting Professor at Nihon University in Tokyo. His influence extends to authorship, with several published works, including two international bestsellers translated into eight languages and distributed in over 30 countries.

In 2019, Dr. Kash delivered a TED Talk in London titled "Entrepreneurship in the Age of Millennials," sharing his expertise on innovation and leadership. He also hosted the nationally syndicated International Spotlight program on FNN (Financial News Network), highlighting emerging trends across industries. Additionally, Dr. Kash serves on the advisory board of Sandbox AQ, a company at the forefront of quantum technology and AI innovation.

With a blend of scientific innovation, academic mentorship, and public engagement, Dr. Kash continues to shape the future of biotechnology and entrepreneurship.